Navigation Links
Creabilis Raises €15M ($20M) in Series B Fundraising Round
Date:10/4/2011

ster@creabilis-sa.com
Creabilis SA
5 rue Jean Monnet L-2810 LUXEMBOURG
                   
Citigate Dewe Rogerson
Chris Gardner or Nina Enegren
Tel: +44(0)20-7282-1050
E-mail: nina.enegren@citigatedr.co.uk

About Creabilis SA

Creabilis is a clinical-stage European biotechnology company creating innovative new drugs to tackle unmet medical needs in dermatology and inflammatory diseases. Bringing together world class drug development capabilities and a rich scientific heritage, Creabilis is uniquely positioned to transform the treatment of its target diseases.

Creabilis' lead product is CT327 a novel topically applied TrkA kinase inhibitor developed using the Company's Low Systemic Exposure (LSE) technology. CT327 is currently in Phase II clinical trials in psoriasis and atopic dermatitis and is undergoing proof-of-concept studies in pain. CT340 is a potent TrkA kinase inhibitor under development for the treatment of conditions in which TrkA kinase inhibition is indicated, including inflammatory arthritis, and pain. The Creabilis portfolio also includes CT637, a new approach to the treatment of significant inflammatory conditions, such as rheumatoid arthritis. Earlier-stage projects include a number of highly promising candidates for dermatological and wider indications.

Creabilis is backed by some of Europe's most highly respected life sciences investors including Sofinnova Partners, Neomed and Abbott Biotech Ventures.

For more information, please visit:  http://www.creabilis-sa.com



'/>"/>
SOURCE Creabilis SA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Creabilis Appoints Dr David Roblin as Chief Medical Officer
2. Creabilis Expands Senior Management Team
3. Bacon Eating Contest Raises Money for American Heart Association
4. Proteolix Raises $79 Million in Series C Financing
5. Yongye Biotechnology International Raises $9.4 Million in Private Placement
6. MacroGenics Raises $25M in Series D-2 Financing
7. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
8. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
9. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
10. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
11. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... a range of resource and environmental problems. Using ... and a clever recycling strategy, Uppsala researchers have ... Their study will be presented soon in the ... our discovery can open several doors to more ... future, says Daniel Brandell, Associate Professor at the ...
(Date:9/29/2014)... Transparency Market Research, in its report titled ... by Application - Cancer, Metabolic, CVS, CNS & others, ... - Global Industry Analysis, Size, Share, Growth, Trends and ... therapeutics market was worth US$14.1 billion in 2011 and ... an 8.7% CAGR. , The two main types of ...
(Date:9/29/2014)... 2014 Burnham Securities Inc. ("Burnham"), a ... a leader in healthcare venture development and strategic ... to expand the range of services each company ... Burnham Securities will be supported by a team ... management in healthcare industry to build a healthcare ...
(Date:9/29/2014)... September 29, 2014 ... competition to transform network connectivity as customers put ... ProLabs , the leading independent provider ... the findings of their survey conducted at the ... top optical communications professionals from across the globe. ...
Breaking Biology Technology:Smart, eco-friendly new battery to solve problems 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 2Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 3End of an Era: OEM Dominance - Could it be a Thing of the Past? 2
... ... efficient. With the most available leg-room, energy efficient impellers, and new service-friendly control panel, ... ... The all-new Allergard 619 Animal Transfer Station (ATS) from NuAire is ergonomic, portable, and ...
... ... and a “fascinatingly weird” ancient culture. , ... (PRWEB) June 11, 2010 -- U.S. nonprofit The OTS Foundation has devised ... megalithic architects in Frequently Asked Question format. With content drawn from a handbook in ...
... , ... more prevalent in clinical research, key issues around open source technology are highlighted at leading ... Washington, DC ... year’s annual meeting of the Drug Information Association (DIA). The DIA Annual Meeting ...
Cached Biology Technology:The Allergard 619: an All-new Animal Transfer Station from NuAire 2New tool for exploring the ancient world. 2Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting 2Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting 3
(Date:9/29/2014)... from 2009, "human activities in this area of the world ... is increasingly grown for use as a cooking oil and ... has become the most widely produced edible oil in the ... that of soybean oil. , The environmental effects of such ... grow the crop, and the preferred method is fire. The ...
(Date:9/29/2014)... team says recently identified radiation detection properties of a ... for homeland security and medical advances. , In a ... of Optics Letters , UT Arlington Physics Professor ... to fabricate transparent nanoscintillators by heating nanoparticles composed of ... formed. A scintillator refers to a material that ...
(Date:9/29/2014)... Washington State University have concluded that nondigestible compounds ... may help prevent disorders associated with obesity. The ... these compounds in apple cultivars grown in the ... the journal Food Chemistry ., "We know ... of these nondigestible compounds but there are differences ...
Breaking Biology News(10 mins):UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3An apple a day could keep obesity away 2
... tough for wildlife living at the frontier between Uganda and ... in a national park and wildlife preserve on the Congolese ... an adjoining Ugandan park. And yet, the profusion of ... individuals of the emblematic African lion, according to new research ...
... in Nevada for turning algae into biofuel has successfully ... of Nevada, Reno. The project is on track to ... energy source in Nevada. University researchers have ... part of their collaborative algae-to-biofuels project with their industry ...
... key phase in the repair process of damaged human ... team of researchers at the University of California, Davis. ... by a protein known as Rad51, which is linked ... The breakthrough comes a decade after Stephen ...
Cached Biology News:Research uncovers surprising lion stronghold in war-torn central Africa 2Research uncovers surprising lion stronghold in war-torn central Africa 3Success for first outdoor, large-scale algae-to-biofuel research project in Nevada 2Human DNA repair process recorded in action 2
... the macro- and micronutrients as ... (1962) and the vitamins as ... (1968). Preparation Quantity Equivalency: Formulated ... powder per liter of medium. ...
... Microarray hybridization chamber assembly (1 each) ... Microarray chamber user guide plastic tweezersChambers ... be cleaned and reused. The chamber is ... Microarray kits and all custom oligo microarrays, ...
Reported to support murine B lymphocytes, hematopoietic tissue from bone marrow, B cells stimulated with lipopolysaccharide, T lymphocytes, and a variety of hybrid cells....
... sequence corresponds to residues 1-18 from rat rab 3D. The ... A - S - A - S - E - P ... D - A - A - D - Q - N(18). ... experiments with the polyclonal antibody that reacts with this product and ...
Biology Products: